Bucetin

CHEMBL1697856 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
223.3 g/mol
LogP
1.8
Phase
4

An analgesic and antipyretic drug that was used to relieve mild to moderate pain and reduce fever. It belongs to the phenacetin family of compounds and was found to carry risks of kidney damage with prolonged use. It has been withdrawn from the market in most countries due to nephrotoxicity concerns.

Moleküler Ağırlık

223,2700 g/mol

LogP

1,80

TPSA

58,60 Ų

Lipinski RO5

Geçer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCOc1ccc(NC(=O)CC(C)O)cc1

InChI

InChI=1S/C12H17NO3/c1-3-16-11-6-4-10(5-7-11)13-12(15)8-9(2)14/h4-7,9,14H,3,8H2,1-2H3,(H,13,15)

Molecular Formula

C12H17NO3

HBD / HBA

2 / 3

Döndürülebilir Bağlar

5

Ağır Atomlar

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

An analgesic and antipyretic drug that was used to relieve mild to moderate pain and reduce fever. It belongs to the phenacetin family of compounds and was found to carry risks of kidney damage with prolonged use. It has been withdrawn from the market in most countries due to nephrotoxicity concerns.

Yes, Bucetin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1697856. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 14130. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.